Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesh:Kaplan-Meier Estimate"" wg kryterium: Temat


Tytuł :
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Autorzy :
Pernot, Simon
Badoual, Cecile
Terme, Magali
Castan, Florence
Cazes, Aurelie
Bouche, Olivier
Bennouna, Jaafar
Francois, Eric
Ghiringhelli, Francois
de la Fouchardiere, Christelle
Samalin, Emmanuelle
Bachet, Jean Baptiste
Borg, Christophe
Ducreux, Michel
Marcheteau, Elie
Stanbury, Trevor
Gourgou, Sophie
Malka, David
Taieb, Julien
Pokaż więcej
Temat :
MESH : Cell Count
MESH : Kaplan-Meier Estimate
MESH: Kaplan-Meier Estimate
MESH : Prognosis
MESH: Male
MESH: Cell Count
MESH : Organoplatinum Compounds
MESH: Treatment Outcome
[ SDV.CAN ] Life Sciences [q-bio]/Cancer
Circulating tumour cells
Stomach neoplasms
MESH: Disease-Free Survival
MESH : Male
MESH : Esophageal Neoplasms
MESH: Antibodies, Monoclonal, Humanized
[SDV.CAN]Life Sciences [q-bio]/Cancer
MESH : Fluorouracil
MESH : Disease Progression
MESH : Female
MESH: Female
MESH: Neoplastic Cells, Circulating
MESH : Treatment Outcome
MESH: Esophageal Neoplasms
MESH: Organoplatinum Compounds
Clinical trial
MESH: Leucovorin
MESH : Esophagogastric Junction
MESH : Leucovorin
MESH: Stomach Neoplasms
Biomarkers
MESH : Stomach Neoplasms
MESH: Humans
MESH: Disease Progression
Prognosis
MESH: Prognosis
MESH: Fluorouracil
MESH : Antibodies, Monoclonal, Humanized
MESH : Humans
MESH: Esophagogastric Junction
MESH : Antineoplastic Combined Chemotherapy Protocols
MESH : Neoplastic Cells, Circulating
MESH : Disease-Free Survival
MESH: Antineoplastic Combined Chemotherapy Protocols
Źródło :
European Journal of Cancer, Elsevier, 2017, 79 (8), pp.15-22. ⟨10.1016/j.ejca.2017.03.036⟩
European journal of cancer (Oxford, England : 1990), 2017, 79 (8), pp.15-22. 〈www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub〉. 〈10.1016/j.ejca.2017.03.036〉
European Journal of Cancer
www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub
European journal of cancer (Oxford, England : 1990)
Tytuł :
Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Autorzy :
Ravinet, Aurelie
Cabrespine, Aurelie
Socie, Gerard
Milpied, Noel
Yakoub Agha, Ibrahim
Nguyen, Stephanie
Michallet, Mauricette
Menard, Anne-Lise
Maillard, Natacha
Mohty, Mohamad
Suarez, Felipe
Huynh, Anne
Marchand, Tony
Deteix, Clemence
Cassuto Jill, Patrice
Maury, Sebastien
Chevallier, Patrice
Oumedaly, Reman
Peffault De Latour, Regis
Bay, Jacques-Olivier
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:HLA Antigens/immunology
Mesh:Transplantation Conditioning/adverse effects
Mesh:Disease-Free Survival
Mesh:Myelodysplastic Syndromes/diagnosis
Mesh:Graft vs Host Disease/prevention & control
Mesh:Proportional Hazards Models
Mesh:Chi-Square Distribution
Mesh:Peripheral Blood Stem Cell Transplantation*/methods
Sciences du Vivant [q-bio]
Mesh:Histocompatibility Testing
Mesh:Treatment Outcome
Mesh:Immunosuppressive Agents/therapeutic use
Mesh:Chronic Disease
Mesh:Recurrence
Mesh:Cyclophosphamide/therapeutic use
Mesh:Myelodysplastic Syndromes/mortality
Mesh:Adult
Mesh:Antilymphocyte Serum/adverse effects
Mesh:Young Adult
Mesh:Dose Fractionation
Mesh:Immunosuppressive Agents/adverse effects
Mesh:Myelodysplastic Syndromes/surgery
Mesh:Bone Marrow Transplantation*/methods
Mesh:Adolescent
Mesh:Busulfan/therapeutic use
Mesh:Myeloablative Agonists/therapeutic use
Mesh:Whole-Body Irradiation
Mesh:Antilymphocyte Serum/therapeutic use
Mesh:Male
Mesh:Bone Marrow Transplantation*/mortality
Mesh:Peripheral Blood Stem Cell Transplantation*/adverse effects
Mesh:Time Factors
Mesh:Humans
Mesh:Acute/immunology
Mesh:Transplantation Conditioning/methods
Mesh:Kaplan-Meier Estimate
Mesh:Acute/diagnosis
Mesh:Acute/mortality
Mesh:Acute/surgery
Mesh:Risk Factors
Mesh:Graft vs Host Disease/immunology
Mesh:Female
Mesh:France
Mesh:Retrospective Studies
Mesh:Unrelated Donors
Mesh:Myelodysplastic Syndromes/immunology
Mesh:Myeloid
Mesh:Histocompatibility
Mesh:Peripheral Blood Stem Cell Transplantation*/mortality
Mesh:Multivariate Analysis
Mesh:Leukemia
Mesh:Transplantation Conditioning/mortality

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies